Suppr超能文献

中国重型β地中海贫血的流行病学与治疗

Epidemiology and treatment of beta thalassemia major in China.

作者信息

Xu Xiaoxiao, Wu Xuedong

机构信息

Departments of pediatrics Nanfang Hospital Southern Medical University Guangzhou Guangdong China.

出版信息

Pediatr Investig. 2019 Oct 28;4(1):43-47. doi: 10.1002/ped4.12154. eCollection 2020 Mar.

Abstract

Thalassemia, classified as the main types α- and β-thalassemia, is a single gene disorder resulting from globin chain synthesis impairment through the mutation or deletion of globin genes. The incidence of thalassemia is high worldwide, with high associated mortality. Therefore, treatment is important to improve patient outcomes. This paper reviews the current status of β-thalassemia major in China, including its epidemiology and treatment.

摘要

地中海贫血分为主要类型的α型和β型,是一种单基因疾病,由珠蛋白基因突变或缺失导致珠蛋白链合成受损引起。地中海贫血在全球发病率很高,相关死亡率也很高。因此,治疗对于改善患者预后很重要。本文综述了中国重型β地中海贫血的现状,包括其流行病学和治疗情况。

相似文献

1
Epidemiology and treatment of beta thalassemia major in China.
Pediatr Investig. 2019 Oct 28;4(1):43-47. doi: 10.1002/ped4.12154. eCollection 2020 Mar.
2
[Research Progress on Thalassemia in Southern China -Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):276-280. doi: 10.7534/j.issn.1009-2137.2017.01.050.
3
Silent thalassemias: genotypes and phenotypes.
Haematologica. 1997 May-Jun;82(3):269-80.
6
Interaction of heterozygous beta zero-thalassemia with single functional alpha-globin gene.
Am J Hematol. 1988 Oct;29(2):63-6. doi: 10.1002/ajh.2830290202.
8
Molecular mechanisms of thalassemia in southeast Asia.
Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:235-40.
9
Thalassemia, a human blood disorder.
Braz J Biol. 2021 Sep 3;83:e246062. doi: 10.1590/1519-6984.246062. eCollection 2021.

本文引用的文献

1
Related and unrelated donor transplantation for β-thalassemia major: results of an international survey.
Blood Adv. 2019 Sep 10;3(17):2562-2570. doi: 10.1182/bloodadvances.2019000291.
3
Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen.
Br J Haematol. 2018 Aug;182(4):554-558. doi: 10.1111/bjh.15438. Epub 2018 Jul 1.
4
[Progress of gene editing technologies and prospect in traditional Chinese medicine].
Zhongguo Zhong Yao Za Zhi. 2017 Jan;42(1):34-40. doi: 10.19540/j.cnki.cjcmm.20161222.003.
5
Thalassemia Major: Transplantation or Transfusion and Chelation.
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):290-298. doi: 10.1016/j.hemonc.2017.05.022. Epub 2017 Jun 20.
6
Thalassemia Minor and Major: Current Management.
Indian J Pediatr. 2017 Aug;84(8):607-611. doi: 10.1007/s12098-017-2325-1. Epub 2017 Apr 24.
7
The prevalence of thalassemia in mainland China: evidence from epidemiological surveys.
Sci Rep. 2017 Apr 19;7(1):920. doi: 10.1038/s41598-017-00967-2.
8
One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection.
Mol Ther Nucleic Acids. 2017 Mar 17;6:57-67. doi: 10.1016/j.omtn.2016.11.010. Epub 2016 Dec 10.
9
New trend in the epidemiology of thalassaemia.
Best Pract Res Clin Obstet Gynaecol. 2017 Feb;39:16-26. doi: 10.1016/j.bpobgyn.2016.10.013. Epub 2016 Oct 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验